Skip to Main Content

Paper Details

EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.
Neuro Oncol
27
2023
(CNS) tumors, ALK, BRAF, BRAF p.V600E, CDK4/6, CNS tumors, EGFR, FGFR, FGFR fusions, MAPK, MDM2/4, NF1, NTRK, NTRK fusions, POLE, RAS, ROS1, TSC1/2, fibroblast growth factor receptor, gliomas, glioneuronal, glioneuronal and neuronal tumors, glioneuronal, and neuronal tumors, homologous recombination deficiency, neurotrophic tyrosine receptor kinase, patients, platelet-derived growth factor receptor alpha, systemic cancers, tumor, tyrosine
Author NameAffiliation
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperGerman Cancer Research Center (DKFZ)
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
David CapperGerman Cancer Research Center (DKFZ)
Guido ReifenbergerInstitute of Neuropathology and German Cancer Consortium (DKTK), Heinrich Heine University, Medical Faculty University Hospital Dusseldorf
Pim J FrenchBrain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam
Leonille SchweizerInstitute of Neurology (Edinger Institute), University Hospital Frankfurt, Goethe University
Leonille SchweizerFrankfurt Cancer Institute (FCI)
Leonille SchweizerGerman Cancer Research Center (DKFZ)
Michael WellerClinical Neuroscience Center, University Hospital and University of Zurich
Mehdi TouatSorbonne Universite, Inserm, CNRS, Institut du Cerveau, Hopitaux Universitaires La Pitie Salpetriere - Charles Foix
Philipp EuskirchenCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Philipp EuskirchenCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, Charite Comprehensive Cancer Center
Philipp EuskirchenCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin
Christine HaberlerMedical University of Vienna
Sebastian BrandnerQueen Square Institute of Neurology, University College London London
Sebastian BrandnerThe National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust
Marc SansonSorbonne Universite, Inserm, CNRS, Institut du Cerveau, Hopitaux Universitaires La Pitie Salpetriere - Charles Foix
Ghazaleh TabatabaiUniversity Hospital Tubingen and Hertie Institute for Clinical Brain Research, Eberhard Karls University Tubingen.
Ghazaleh TabatabaiCenter for Neuro-Oncology, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen.
Ghazaleh TabatabaiEberhard Karls University Tubingen.
Felix SahmUniversity Hospital Heidelberg
Felix SahmGerman Cancer Research Center (DKFZ)
Felix SahmUniversity Hospital Heidelberg
Felix SahmGerman Cancer Research Center (DKFZ)
Patrick Y WenCenter For Neuro-Oncology, Dana-Farber Cancer institute and Harvard Medical School
Matthias PreusserMedical University of Vienna
Matthias PreusserMedical University of Vienna
  • 1 - 28

Datasets